Diabetes Drug Raises Heart Risk

This WisdomCard features top online resources on this topic

A recent study confirms that Avandia (rosiglitazone) is linked with an increased risk of heart failure and death. Avandia is used to control blood sugar levels in those withtype 2 diabetes. Researchers feel that there is no justification for using Avandia over another drug calledpioglitazone.¹

Fast Facts:

• For every 93 patients using rosiglitazone, it is estimated that there will be one extra cardiovascular death each year.²
• Data from around 40,000 patient records was used for this study.²
• This study is published in the August 2009 BMJ.

Is stress making you sick? Take a FREE Life Stress Test!See which celebs are living with mental illness

The Top 10 Resources on Diabetes Drug Raises Heart Risk

Selected by our Guides and Physician Review Team

1. Medical News Today: A Drug Used To Treat Type 2 Diabetes Is Associated To Increased Risk Of Heart Failure (Aug. 19, 2009)
2. Bloomberg: Glaxo’s Avandia Has More Heart Risks Than Actos, Study Finds (Aug. 19, 2009)
3. Medpage Today: No Cardiovascular Class Effect with Thiazolidinediones (Aug. 19, 2009)
4. Press Association: Diabetes Drug Raises Heart Risk(Aug. 19, 2009)
5. Reuters: Glaxo's Avandia Riskier Than Takeda Drug(Aug. 19, 2009)
6. CTV: Actos Safer for Heart Than Avandia, Study Suggests (Aug. 18, 2009)
7. Vancouver Sun: Diabetes Drug Could Lead to Heart Failure (Aug. 18, 2009)